Sequence alignment reveals possible MAPK docking motifs on HIV proteins

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Evans, Perry ^a   Sacan, Ahmet ^b   Ungar, Lyle ^a   Tozeren, Aydin ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; NEF PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIF PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BIOINFORMATICS; COMPUTER MODEL; HUMAN; NONHUMAN; PHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN MOTIF; SEQUENCE ALIGNMENT; VIRUS STRAIN;

HIV; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN BINDING; SEQUENCE ALIGNMENT; VIRAL PROTEINS;

EID: 77952538851     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008942     Document Type: Article

References (30)

1. Yang X, Gabuzda D (1999) Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway. Am Soc Microbiol. pp 3460-3466.
2. Bukrinskaya AG, Ghorpade A, Heinzinger NK, Smithgall TE, Lewis RE, et al. (1996) Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. National Acad Sciences. pp 367-371.
3. Barraud P, Paillart JC, Marquet R, Tisne C (2008) Advances in the structural understanding of Vif proteins. Current HIV Research 6: 91-99.
4. Toschi E, Bacigalupo I, Strippoli R, Chiozzini C, Cereseto A, et al. (2006) HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway. Molecular biology of the cell 17: 1985.
5. Schrager JA, Der Minassian V, Marsh JW (2002) HIV Nef increases T cell ERK MAP kinase activity. Journal of Biological Chemistry 277: 6137.
6. Yang X, Gabuzda D (1998) Mitogen-activated protein kinase phosphorylates and regulates the HIV-1 Vif protein. Journal of Biological Chemistry 273: 29879-29887.
7. Pan C, Olsen JV, Daub H, Mann M (2009) Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics. Molecular & Cellular Proteomics: M900285.
8. Ohori M, Kinoshita T, Okubo M, Sato K, Yamazaki A, et al. (2005) Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex. Biochemical and Biophysical Research Communications 336: 357-363.
9. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (2002) The protein kinase complement of the human genome. Science 298: 1912.
10. Burkhard K, Smith S, Deshmukh R, MacKerell AD Jr, Shapiro P (2009) Development of Extracellular Signal-Regulated Kinase Inhibitors. Current Topics in Medicinal Chemistry 9: 678-689.
11. Hancock CN, Macias AT, Mackerell AD Jr, Shapiro P (2006) Mitogen activated protein (MAP) kinases: development of ATP and non-ATP dependent inhibitors. Medicinal chemistry (Sh riqah (United Arab Emirates)) 2: 213.
12. Bardwell AJ, Frankson E, Bardwell L (2009) Selectivity of docking sites in MAPK kinases. Journal of Biological Chemistry 284: 13165.
13. Puntervoll P, Linding R, Gemünd C, Chabanis-Davidson S, Mattingsdal M, et al. (2003) ELM server: a new resource for investigating short functional sites in modular eukaryotic proteins. Nucleic Acids Research 31: 3625-3630.
14. Reményi A, Good MC, Lim WA (2006) Docking interactions in protein kinase and phosphatase networks. Current opinion in structural biology 16: 676-685.
15. Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM (2008) The challenge of HIV-1 subtype diversity. New England Journal of Medicine 358: 1590.
16. Dampier W, Evans P, Ungar L, Tozeren A (2009) Host sequence motifs shared by HIV predict response to antiretroviral therapy. BMC Medical Genomics 2: 47.
17. Bardwell L (2006) Mechanisms of MAPK signalling specificity. Biochemical Society Transactions 34: 837-841.
18. Liu S, Sun JP, Zhou B, Zhang ZY. Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3; 2006. National Acad Sciences.
19. Lee TY, Huang HD, Hung JH, Huang HY, Yang YS, et al. (2006) dbPTM: an information repository of protein post-translational modification. Nucleic Acids Research 34: D622.
20. Finn RD, Tate J, Mistry J, Coggill PC, Sammut SJ, et al. (2008) The Pfam protein families database. Nucl Acids Res 36: D281-288.
21. Hemelaar J, Gouws E, Ghys PD, Osmanov S (2006) Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. Aids 20: W13.
22. Lin HY, Zhang SL, West BL, Tang HY, Passaretti T, et al. (2003) Identification of the Putative MAP Kinase Docking Site in the Thyroid Hormone Receptorbeta 1 DNA-Binding Domain: Functional Consequences of Mutations at the Docking Site. Biochemistry 42: 7571-7579.
23. Zhang Y, Skolnick J (2004) Scoring function for automated assessment of protein structure template quality. Proteins: Structure, Function, and Bioinformatics 57.
24. Chen R, Li L, Weng Z (2003) ZDOCK: an initial-stage protein-docking algorithm. Proteins Structure Function and Genetics 52: 80-87.
25. Kinoshita T, Yoshida I, Nakae S, Okita K, Gouda M, et al. (2008) Crystal structure of human mono-phosphorylated ERK1 at Tyr204. Biochemical and Biophysical Research Communications 377: 1123-1127.
26. Deeks SG (2003) Treatment of antiretroviral-drug-resistant HIV-1 infection. The Lancet 362: 2002-2011.
27. Evans P, Dampier W, Ungar L, Tozeren A (2009) Prediction of HIV-1 virus-host protein interactions using virus and host sequence motifs. BMC Medical Genomics 2: 27.
28. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J mol Biol 215: 403-410.
29. Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, et al. (2002) The protein data bank. Acta Crystallographica Section D: Biological Crystallography 58: 899-907.
30. Sacan A, Toroslu IH, Ferhatosmanoglu H (2008) Integrated search and alignment of protein structures. Bioinformatics 24: 2872.